Larvol Delta - BPGbio-Announces-First-Patients-Dosed-in-Phase-2-Trial-of-AIDeveloped-BPM-31510-for-Glioblastoma-Multiforme

ubidecarenone topical (BPM 31510) - BPGbio

https://www.businesswire.com/news/home/20230606005463/en/BPGbio-Announces-First-Patients-Dosed-in-Phase-2-Trial-of-AI-Developed-BPM-31510-for-Glioblastoma-Multiforme

Jun 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next